Docosahexaenoic Acid Market Analysis

  • Report ID: 3946
  • Published Date: Jun 07, 2024
  • Report Format: PDF, PPT

Docosahexaenoic Acid Market Analysis

Type (Fish Oil DHA, Algae DHA)

The algae docosahexaenoic acid market is estimated to gain around 61% market share in the coming years owing to the rising application of algae-based omega-3s in infant food. Algae oil is used as a substitute to fish in baby milk and food and is considered a primary source of omega-3 fats. It is used in formulations for newborns and young children in powder form since it is high in the omega-3 fats EPA and DHA.

In addition, more than 500 human goods now employ the omega-3 oil that comes from these algae which is also known as a vegetarian source of docosahexaenoic acid.

End-User (Breastfeeding Mothers, Infants, Pregnant Mothers)

The pregnant mothers segment in the docosahexaenoic acid market is set to garner a notable share in the near future driven by the growing demand for DHA in pregnant mothers. Pregnant women must consume sufficient levels of DHA to improve the quality of their pregnancies and the health of their fetuses. A growing body of research indicates that pregnant women may benefit from taking supplements of omega-3 fatty acids, particularly DHA, which may aid in maintaining a healthy birth weight.

Our in-depth analysis of the global market includes the following segments:

     Type

  • Fish Oil DHA
  • Algae DHA

     Form

  • Powder
  • Liquid

     Application

  • Improving memory
  • Brain development

     End-User

  • Breastfeeding Mothers
  • Infants
  • Pregnant Mothers
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Parul Atri


  • Report ID: 3946
  • Published Date: Jun 07, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of docosahexaenoic acid is estimated at USD 4.42 Billion.

The docosahexaenoic acid market size was over USD 4.1 Billion in 2023 and is poised to cross USD 13.62 Billion by the end of 2036, witnessing more than 10% CAGR during the forecast period i.e., between 2024-2036. Escalating cases of depression and surging risk of preterm births across the globe are the major factors driving the growth of the market.

Asia Pacific industry is predicted to account for the largest share of about 42% by 2036, impelled by growing healthcare expenditure in the region.

Koninklijke DSM N.V., BASF SE, Croda International Plc, Cellana, Inc., Far East Microalgae Industries, Co., Ltd.(FEMICO), Pelagia AS, Corbion NV, JC Biotech Private Limited, Source Omega LLC, Shandong Yuexiang Biotechnology Co., Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample